Back

Association of clinical characteristics and biomarkers with recurrent atrial fibrillation after hybrid ablation

16 April 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: ePoster session 22 Rhythm Control, Hybrid Therapy EHRA Premium Access EHRA 2023

About the speaker

Photo
Miss Marieke Velt

Wildervank (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion
Doctor D. Della Rocca (Brussels, BE)
Abstract Slides
Presentation thumbnail
Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation
Miss R. Van Der Velden (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Size matters - body size and acute device-implantation failure after LAAC
Mr D. Zweiker (Vienna, AT)
Abstract Slides
Presentation thumbnail
Meta-analysis on clinical utility of oesophageal temperature monitoring in AF ablation
Doctor D. Khanra (CHESTER, GB)
Abstract Slides
Presentation thumbnail
The impact of posterior wall ablation in conjunction with pulmonary vein isolation in patients with persistent atrial fibrillation: a meta-analysis comparing cryoballoon vs. radiofrequency energy
Doctor D. Musat (Paramus, US)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 22

The Event

Event poster

EHRA 2023

16 April - 18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources